...
首页> 外文期刊>Kemija u industriji >Biocatalysis for the Production of pharmaceutical Intermediates: Statin Precursors
【24h】

Biocatalysis for the Production of pharmaceutical Intermediates: Statin Precursors

机译:生物催化分析制药中间体:汀类药物前体

获取原文
获取原文并翻译 | 示例
           

摘要

The application of enzymes in chemical synthesis,due to the recent advances,has a strong impact in multiple industries,especially the pharmaceutical industry.Namely,the use of enzymes shows remarkable advantages over classical chemical catalysis and therefore it is considered a’green’solution.By using novel techniques,it is possible to tailor the enzymes to adapt them for a given process.Today,several pharmaceutical companies are successfully producing valuable precursors for the production of active pharmaceutical ingredients using enzymes,some of them being statin precursors.Statins are hypolipidemics,drugs used for the prevention of cardiovascular diseases and lowering cholesterol concentration in blood.Due to challenges in the chemical synthesis of statin intermediates,the production of statin intermediates using enzyme-catalysed reactions shows some notable advantages.Therefore,research and development laboratories,combined with reaction engineering techniques,have shifted their focus towards applying biochemical catalysis for the production of statin intermediates.
机译:酶在化学合成中的应用,由于最近的进步,对多个行业产生了强烈影响,特别是制药业。酶的使用呈现出古典化学催化的显着优势,因此它被认为是A'Green的实际使用新颖的技术,可以定制酶以使其适应给定的过程。这是几种制药公司使用酶成功生产有效药物成分的宝贵前体,其中一些是他汀类药物前体.statins是低血散,用于预防心血管疾病的药物,降低血液中的胆固醇浓度。用酶催化反应的化学合成化学合成中的挑战,使用酶催化反应产生了一些显着的优势。因此,研究和开发实验室,结合反应工程技术,转移了它们的f OCUS对应用生物化学催化作用的西汀蛋白中间体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号